RecruitingNCT06111430

Long-term Neurovascular Complications After Radiation Therapy in Head and Neck Cancer

The Ambidirectional Cohort Study of Neurovascular Complications After Radiation Therapy in Head and Neck Cancer Patients


Sponsor

Chang Gung Memorial Hospital

Enrollment

800 participants

Start Date

Apr 11, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

Head and neck cancer is a group of cancers develop from the soft tissues, salivary gland, mucosa of the upper respiratory or digestive system covering the oral and nasal cavity. Radiotherapy is usually the standard treatment of Head and neck cancers. In the present study, investigators aim to study the prevalence of cervical-cranial vascular complications during the early stages in these Head and neck cancer patients receiving Radiotherapy. Investigators will also compare the results between Nasopharyngeal cancer and other Head and neck cancerpatients receiving Radiotherapy.


Eligibility

Min Age: 20 YearsMax Age: 100 Years

Inclusion Criteria9

  • Population: Prospective cohort
  • Age ≥20 years.
  • Head and neck cancer patient .
  • Had ever received radiation therapy (RT) ≦ 72 months before inclusion in the registry.
  • Had ≥ 1 brain images and cervical-cranial vascular studies between the end of RT and d date of enrolment.
  • Age ≥20 years.
  • Head and neck cancer patient.
  • Had ever received radiation therapy (RT) \> 120 months before the adoption date of IRB at the participant site.
  • Had ≥ 2 brain images and cervical-cranial vascular studies between the end of RT and 6\~10 years after RT, one within 5 years after RT, the other after 5 years after RT.

Exclusion Criteria4

  • Age \<20 years.
  • Patients not willing to sign the informed consent.
  • Population: Retrospective validation cohort
  • Age \<20 years.

Locations(1)

Chang Gung Memorial Hospital

Taipei, Taiwan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06111430